Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Operating Expenses | 5,872 | 36 | 20 | 11 | 2,714 |
| Operating Income | -5,722 | -36 | -20 | -11 | -2,284 |
| Other Income | 31 | 4 | 8 | 1 | -9 |
| Pre-tax Income | -5,691 | -32 | -13 | -10 | -2,293 |
| Net Income Continuous | -5,691 | -32 | -13 | -10 | -2,293 |
| Net Income | $-5,691 | $-32 | $-13 | $-10 | $-2,293 |
| EPS Basic Total Ops | -2.10 | -1.00 | 0.00 | 0.00 | 2.70 |
| EPS Basic Continuous Ops | -1.21 | -1.10 | -0.44 | -0.36 | 3.11 |
| EPS Diluted Total Ops | -2.10 | -1.00 | 0.00 | 0.00 | 2.70 |
| EPS Diluted Continuous Ops | -1.21 | -1.10 | -0.44 | -0.36 | 3.11 |
| EBITDA(a) | $-5,872 | $-36 | $-20 | $-11 | $-2,714 |